Summary by Moomoo AI
In8bio, Inc. (INAB) has reported a transaction involving its Chief Operating Officer, Kate Rochlin. The transaction took place on February 7, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and post-transaction holdings were not disclosed in the announcement. This information is typically significant for investors as it provides insight into the actions of a company's high-level executives, which can be indicative of their confidence in the company's future performance.